Targeting Gene C9orf72 Pathogenesis for Amyotrophic Lateral Sclerosis.

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with no cure.
• C9orf72 gene mutations, specifically hexanucleotide repeat expansions (HRE), are the most common genetic cause of ALS.
• Understanding the pathogenic mechanisms of C9orf72 HRE is critical for therapeutic development.

Purpose of the Study:

• To review the literature on the pathogenesis of C9orf72 HRE in ALS.
• To elucidate the dual gain-of-function and loss-of-function mechanisms.
• To discuss current therapeutic strategies and future directions.

Main Methods:

• Literature review of studies on C9orf72 mutations and ALS pathogenesis.
• Analysis of molecular mechanisms including RNA foci and dipeptide repeat (DPR) formation.
• Examination of C9ORF72 protein function and its cellular roles.

Main Results:

• C9orf72 HRE causes toxic gain-of-function through RNA foci and DPRs, disrupting RNA processing, protein interactions, and cellular functions.
• HRE leads to loss of C9ORF72 function, impairing autophagy, increasing oxidative stress, and causing inflammation.
• Current therapeutic approaches targeting C9orf72 HRE have shown limited success.

Conclusions:

• C9orf72 HRE pathogenesis is complex, involving both toxic gain-of-function and loss-of-function.
• Further research into pharmacological and molecular modulators targeting C9orf72 HRE is necessary.
• Developing effective ALS therapies requires a deeper understanding and precise targeting of these genetic defects.